Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 184Neoplasm Metastasis 149Neoplasms 140Leukemia, Myeloid, Acute 133Colorectal Neoplasms 131Breast Neoplasms 122Melanoma 94Ovarian Neoplasms 93Recurrence 88Prostatic Neoplasms 88Multiple Myeloma 84Pancreatic Neoplasms 76Squamous Cell Carcinoma of Head and Neck 74Lung Neoplasms 74Glioblastoma 74Lymphoma, Non-Hodgkin 67Myelodysplastic Syndromes 62Triple Negative Breast Neoplasms 58Glioma 56Precursor Cell Lymphoblastic Leukemia-Lymphoma 53Stomach Neoplasms 52Endometrial Neoplasms 50Brain Neoplasms 48Carcinoma, Renal Cell 47Small Cell Lung Carcinoma 46Lymphoma, Large B-Cell, Diffuse 46Carcinoma, Hepatocellular 45Lymphoma, Follicular 41Lymphoma, B-Cell 41Sarcoma 40

Interventions

pembrolizumab 1Fluorouracil 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Malignant Solid Tumor × 90 days × Clear all
NCT06057038 2026-06-02

A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid Tumors

Genmab

Phase 1 Active not recruiting
42 enrolled
Other solid neoplasm

Malignant Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡